LATEST NEWS

Sydney Ramirez was told that a career in medicine AND research would be impossible. She’s glad she didn’t listen.
Li launches new lab at an exciting time for novel immunotherapeutics and vaccine innovations
The new Rad Lab at LJI studies the cells behind our antibodies—and aims to guide the development of better vaccines, tests, and treatments.
Team leader Erik Ehinger, Ph.D., is on a mission to help more patients benefit from cancer immunotherapies.
LJI scientists tested two Zika vaccines, both designed to work through antibodies. One protected through T cells instead—but only the vaccine that mustered both held off the virus for the long haul.
LJI scientists investigate how “tissue-resident” immune cells contribute to lung and autoimmune diseases.
LJI scientists are the first to provide a comprehensive look at how tissue-resident memory T cells combat infections in human lung tissue
Vaccine approach yields high numbers of HIV-neutralizing antibodies in non-human primates
Physician-scientist L. Benjamin Hills wins prestigious Irvington Postdoctoral Award to study immune cells in young cancer patients